Ming Chu

1.1k total citations
52 papers, 810 citations indexed

About

Ming Chu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ming Chu has authored 52 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Immunology. Recurrent topics in Ming Chu's work include Berberine and alkaloids research (5 papers), Glycosylation and Glycoproteins Research (4 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Ming Chu is often cited by papers focused on Berberine and alkaloids research (5 papers), Glycosylation and Glycoproteins Research (4 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Ming Chu collaborates with scholars based in China, United States and United Kingdom. Ming Chu's co-authors include Zheng-yun Chu, Yuedan Wang, Mingbo Zhang, Yimiao Zhu, Zhou Zhou, Ran Ding, Yuedan Wang, Lan Xu, Jiarui Kang and Xiaoyan Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Ming Chu

49 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Chu China 15 279 173 136 114 101 52 810
Arshad Jawed India 21 509 1.8× 94 0.5× 145 1.1× 57 0.5× 115 1.1× 72 1.1k
Xichun Pan China 17 291 1.0× 81 0.5× 117 0.9× 59 0.5× 74 0.7× 32 744
Youness Limami Morocco 18 404 1.4× 72 0.4× 111 0.8× 115 1.0× 271 2.7× 43 1.1k
Jing Pang China 19 305 1.1× 194 1.1× 41 0.3× 92 0.8× 78 0.8× 71 954
Yanyan Cen China 17 241 0.9× 51 0.3× 124 0.9× 61 0.5× 56 0.6× 23 632
Wen Xiong China 16 306 1.1× 50 0.3× 172 1.3× 108 0.9× 60 0.6× 48 860
Joey Leung United States 11 340 1.2× 126 0.7× 254 1.9× 46 0.4× 219 2.2× 14 1.1k
Dahong Ju China 19 517 1.9× 77 0.4× 107 0.8× 115 1.0× 51 0.5× 43 911
Faris Q Alenzi Saudi Arabia 17 325 1.2× 49 0.3× 90 0.7× 53 0.5× 84 0.8× 70 1.1k

Countries citing papers authored by Ming Chu

Since Specialization
Citations

This map shows the geographic impact of Ming Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Chu more than expected).

Fields of papers citing papers by Ming Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Chu. The network helps show where Ming Chu may publish in the future.

Co-authorship network of co-authors of Ming Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Chu. A scholar is included among the top collaborators of Ming Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Chu. Ming Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Pinghua, Ziyuan Wang, Yuan Liu, et al.. (2025). Advance in identified targets of berberine. Frontiers in Pharmacology. 16. 1500511–1500511. 5 indexed citations
2.
Liu, Mengqi, et al.. (2023). Strategies targeting IL-33/ST2 axis in the treatment of allergic diseases. Biochemical Pharmacology. 218. 115911–115911. 3 indexed citations
3.
Chen, Xi, et al.. (2023). RISK-GPT: Using ChatGPT to construct a reliable risk factor database for all known diseases. Journal of Global Health. 13. 4 indexed citations
4.
Xu, Jing, Xiaoxiao Li, Na Yuan, et al.. (2023). T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures. Frontiers in Immunology. 14. 1190844–1190844. 4 indexed citations
5.
Gong, Li-Hua, et al.. (2023). Single-cell and bulk tissue sequencing unravels the heterogeneity of synovial microenvironment in arthrofibrosis. iScience. 26(9). 107379–107379. 2 indexed citations
6.
Chu, Ming, et al.. (2022). Advances in Immunosuppressive Agents Based on Signal Pathway. Frontiers in Pharmacology. 13. 917162–917162. 18 indexed citations
7.
Chen, Xi, Ziyuan Wang, Jing Wang, et al.. (2022). Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2. Frontiers in Pharmacology. 13. 940628–940628. 6 indexed citations
8.
Wang, Qianqian, Dongyang Jiang, Qing Ye, et al.. (2022). A widely expressed free immunoglobulin κ chain with a unique Vκ4-1/Jκ3 pattern promotes colon cancer invasion and metastasis by activating the integrin β1/FAK pathway. Cancer Letters. 540. 215720–215720. 11 indexed citations
9.
Zhou, Zhou, Yimiao Zhu, & Ming Chu. (2022). Role of COVID-19 Vaccines in SARS-CoV-2 Variants. Frontiers in Immunology. 13. 898192–898192. 62 indexed citations
10.
Chen, Xi, et al.. (2021). Identification of novel biomarkers for arthrofibrosis after total knee arthroplasty in animal models and clinical patients. EBioMedicine. 70. 103486–103486. 10 indexed citations
11.
Song, Jie, Jie Yang, Chong Yan, et al.. (2021). Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets. Journal of Neuroimmunology. 362. 577787–577787. 7 indexed citations
12.
Zhang, Chi, Yan Huang, Li Zhang, et al.. (2020). NBIGV-DB: A dedicated database of non-B cell derived immunoglobulin variable region. Gene. 772. 145378–145378. 5 indexed citations
13.
Chu, Ming, Caihong Jiang, Xi Chen, et al.. (2018). Staphylococcus aureus Phenol-Soluble Modulins α1–α3 Act as Novel Toll-Like Receptor (TLR) 4 Antagonists to Inhibit HMGB1/TLR4/NF-κB Signaling Pathway. Frontiers in Immunology. 9. 862–862. 28 indexed citations
14.
Yin, Kailin, Yanchen Liu, Ming Chu, & Yuedan Wang. (2017). TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer. PLoS ONE. 12(1). e0170573–e0170573. 5 indexed citations
15.
16.
Ding, Lingyu, Ming Chu, Tieshan Wang, et al.. (2017). Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro. PLoS ONE. 12(8). e0182781–e0182781. 7 indexed citations
17.
Chu, Ming, Mingbo Zhang, Yanchen Liu, et al.. (2016). Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections. Scientific Reports. 6(1). 24748–24748. 97 indexed citations
18.
Zhang, Lijuan, He Huang, Luyao Deng, et al.. (2008). TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicology. 252(1-3). 49–55. 19 indexed citations
19.
Hu, Yi, Ren Xiang Tan, Ming Chu, & Jing Zhou. (2000). Apoptosis in Human Hepatoma Cell Line SMMC‐7721 Induced by Water‐soluble Macromolecular Components of Artemisia capillaris Thunberg. Japanese Journal of Cancer Research. 91(1). 113–117. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arshad Jawed Breakdown of academic impact, for papers by Xichun Pan Breakdown of academic impact, for papers by Youness Limami Breakdown of academic impact, for papers by Jing Pang Breakdown of academic impact, for papers by Yanyan Cen Breakdown of academic impact, for papers by Wen Xiong Breakdown of academic impact, for papers by Joey Leung Breakdown of academic impact, for papers by Dahong Ju Breakdown of academic impact, for papers by Faris Q Alenzi
Rankless by CCL
2026